Medical Properties Trust (MPW) insider reports 59K share sale

Rhea-AI Filing Summary

Medical Properties Trust, Inc. (MPW) director W. Zachary Riddle reported a sale of company stock. On 11/19/2025, he sold 59,000 shares of common stock at a weighted average price of $5.02 per share, with individual trade prices ranging from $4.99 to $5.05. After this transaction, he beneficially owned 157,100 shares of MPW common stock in direct ownership. The trades were executed in multiple transactions, and full trade details are available upon request as noted in the filing.

Insider Trade Summary

Net Seller: 59,000 shares ($296,180)

Net Sell 1 txn

Insider Stewart Michael G

Role Director

Sold 59,000 shs ($296K)

Type	Security	Shares	Price	Value
Sale	Common stock, par value $0.001	59,000	$5.02	$296K

Holdings After Transaction: Common stock, par value $0.001 — 157,100 shares (Direct)

Footnotes (1)

1. [object Object]

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/21/2025 - 05:30 PM Learn about SEC filing dates

FAQ

What insider transaction did MPW disclose in this Form 4?

The Form 4 reports that director W. Zachary Riddle sold 59,000 shares of Medical Properties Trust, Inc. (MPW) common stock on 11/19/2025.

At what price were the MPW shares sold in this insider transaction?

The reported transaction used a weighted average sale price of $5.02 per MPW share, with individual trades executed at prices ranging from $4.99 to $5.05.

How many MPW shares does the reporting person own after the sale?

Following the reported sale, W. Zachary Riddle beneficially owned 157,100 shares of MPW common stock in direct ownership.

What is the relationship of the reporting person to Medical Properties Trust (MPW)?

The reporting person, W. Zachary Riddle, is identified as a director of Medical Properties Trust, Inc.

Were the MPW insider sales executed in a single trade or multiple trades?

The sales were executed in multiple trades at prices between $4.99 and $5.05 per share, as explained in the response section.

Does the Form 4 provide more detailed trade information for the MPW stock sale?

Yes. The filing states that full information on the number of shares and prices for each trade will be provided upon request to the SEC staff, the issuer, or a security holder.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stewart Michael G

(Last) (First) (Middle)

1000 URBAN CENTER DRIVE

SUITE 501

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MEDICAL PROPERTIES TRUST INC [ MPW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	11/19/2025		S		59,000	D	$5.02(1)	157,100	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $4.99 to $5.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	W. Zachary Riddle, by power of attorney	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.